Forvis Mazars Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$712K	Buy	1,600 +152	+10%	+$67.7K	0.02%	239
2025 Q1	$702K	Buy	+1,448	New	+$702K	0.02%	239
2020 Q4	–	Sell	-847	Closed	-$230K	–	360
2020 Q3	$230K	Buy	847 +35	+4%	+$9.5K	0.01%	294
2020 Q2	$236K	Buy	+812	New	+$236K	0.02%	278